📇 Rhumatologue · Troyes · (10) · Hospitalier
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien essentiel en désert médical
Seulement 3.5 rhumatologues / 100 000 habitants dans votre département (moyenne nationale ≈ 5.6) — chaque praticien compte
Auteur de référence en rhumatologie
38 articles scientifiques publiés — un praticien à la pointe de la recherche
✨ Génération du profil synthétique IA en cours…
🎓 DES & spécialité ordinale
🎓 Diplômes
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
CENTRE HOSPITALIER DE TROYES
101 Avenue ANATOLE FRANCE, 10003 Troyes
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of medical virology · 2022
AbstractThe entire world has been suffering from the coronavirus disease 2019 (COVID‐19) pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought hope to control this viral pandemic. Here, we review the unknowns of the COVID‐19 vaccination, such as its longevity, asymptomatic spread, long‐term side effects, and its efficacy on immunocompromised patients. In addition, we discuss challenges associated with the COVID‐19 vaccination, such as the global access and distribution of vaccine doses, adherence to hygiene guidelines after vaccination, the emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants, and vaccine resistance. Despite all these challenges and the fact that the end of the COVID‐19 pandemic is still unclear, vaccines have brought great hope for the world, with several reports indicating a significant decline in the risk of COVID19‐related infection and hospitalizations.
Lupus · 2008
Mycophenolate mofetil (MMF) with prednisolone has been associated with high remission rates when used as induction treatment for lupus nephritis. This prospective, multicentre, cohort study investigates the efficacy and safety of this regimen over 24 weeks in 213 Chinese patients with active lupus nephritis (Classes III, IV, V or combination). Baseline activity index (AI) was 6.91 ± 3.33 and chronicity index (CI) was 1.9 ± 1.2. The remission rate was 82.6% at 24 weeks (complete remission, 34.3%; partial remission, 48.4%). There were significant ( P < 0.01) improvements in kidney function shown by reductions in proteinuria, serum albumin, serum creatinine and creatinine clearance, as well as in systemic lupus erythematosus disease activity index (SLEDAI) scores. Independent risk factors influencing remission were pathological classification (including Class V and III or Class V and IV nephritis) and elevated serum creatinine at baseline (OR 2.967, 95% CI: 1.479–6.332, P = 0.001 and OR 1.007, 95% CI: 1.002–1.011, P = 0.001, respectively). Patients with concomitant membranous features on biopsy had a lower remission rate than those with Class III and IV nephritis (66.7% vs 87.3%, P = 0.002). Renal biopsy was repeated in 25 patients following treatment. There was a transition to less severe pathological morphologies in majority of subjects. Infections were monitored throughout treatment: eight patients (3.8%) experienced bacterial infections, whereas herpes zoster occurred in seven patients. Nine patients (4.2%) suffered from gastrointestinal upset, which resolved without discontinuation of MMF. One patient became leucopenic, whereas another died from active disease unrelated to kidney symptoms. MMF combined with prednisolone is an effective and well-tolerated induction treatment for patients with active lupus nephritis and for controlling SLE systemic activity.
North American journal of medical sciences · 2009
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Case reports in anesthesiology · 2025 · Journal Article
Rebai L, Sammari S, Faten O, Kalai F, et al.
Surgical neurology international · 2025 · Case Reports
Gader G, Mzoughi E, Faten O, Zehani A, et al.
Surgical neurology international · 2025 · Journal Article
Rebai L, Nsiri W, Kalai F, Ben Brahem S, et al.
Surgical neurology international · 2025 · Case Reports
Kalai F, Sammari S, Rebai L, Ben Brahem S, et al.
Clinical and experimental dental research · 2023 · Journal Article
Khaireddine H, Mohamed T, Arij R, Faten K, et al.
Clinical Medicine Insights. Cardiology · 2023 · Journal Article
Mouna E, Molka BB, Sawssan BT, Dhoha BS, et al.
Journal of medical virology · 2022 · Journal Article
Mohamed K, Rzymski P, Islam MS, Makuku R, et al.
Dermatologic therapy · 2021 · Journal Article
Safa I, Ines L, Noureddine L, Meriem J, et al.
Advances in experimental medicine and biology · 2021 · Journal Article
Mohamed K, Makuku R, Rodríguez-Román E, Hejleh APA, et al.
JGH open : an open access journal of gastroenterology and hepatology · 2020 · Journal Article
Wafa B, Faten H, Mouna E, Fatma M, et al.
BioMed research international · 2020 · Journal Article
Maran S, Faten SA, Lim SE, Lai KS, et al.
PloS one · 2020 · Journal Article
Maran S, Ee R, Faten SA, Sy Bing C, et al.
Drug design, development and therapy · 2019 · Journal Article
Kameoka Y, F K, M K
Molecules and cells · 2018 · Journal Article
Alfhili MA, Yoon DS, Faten TA, Francis JA, et al.
Bulletin du cancer · 2018 · Journal Article
Faten E, Nader M, Raies H, Sana M, et al.
Nephrologie & therapeutique · 2018 · Case Reports
Yoldez H, Ahlem B, Abderrahim E, Faten Z, et al.
Journal of immunoassay & immunochemistry · 2018 · Journal Article
Mezni F, Mlika M, Boussen H, Ghedira H, et al.
Journal of orthopaedic case reports · 2016 · Case Reports
R M, D VV, A LG, P G, et al.
European annals of otorhinolaryngology, head and neck diseases · 2015 · Journal Article
Ahlem B, Wided A, Amani L, Nadia Z, et al.
The open rheumatology journal · 2014 · Journal Article
F E A, N K, H A, F L, et al.
World journal of oncology · 2010 · Journal Article
Olfa G, Amel T, Rim C, Aymen Z, et al.
North American journal of medical sciences · 2009 · Case Reports
Amel T, Olfa G, Faten H, Makrem H, et al.
La Tunisie medicale · 2007 · Comparative Study
Mrad SM, Boukthir S, Gharsallah L, Bouyahia O, et al.
La Tunisie medicale · 2006 · Case Reports
Rammeh-Rommani S, Zermani R, Bettaieb I, Kourda N, et al.
La Tunisie medicale · 2005 · English Abstract
Jalel T, Faouzi H, Faten T, Abdellatif A, et al.
Joint bone spine · 2005 · Journal Article
Héla S, Nihel M, Faten L, Monia F, et al.
La Tunisie medicale · 2005 · English Abstract
Sana T, Bécima F, Rachida Z, Olfa K, et al.
Surgical neurology international · 2025 · Case Reports
Kalai F, Rebai L, Sammari S, Faten O, et al.
International journal of surgery case reports · 2023 · Case Reports
Racem T, Mehdi D, Ahmed G, Faten S, et al.
International journal of surgery case reports · 2020 · Case Reports
Daghmouri MA, Ben Ismail I, Ouesleti M, Tarhouni MA, et al.
Case reports in critical care · 2021 · Case Reports
Daghmouri MA, Ouesleti M, Touati MA, Faten O, et al.
African health sciences · 2016 · Journal Article
Samia H, Khadija B, Agnes H, Fatma K, et al.
Pediatric dermatology · 2015 · Case Reports
Mouna K, Akkari H, Faten H, Yosra K, et al.
Surgical neurology international · 2025 · Case Reports
Kalai F, Rebai L, Sammari S, Faten O, et al.
Case reports in critical care · 2021 · Case Reports
Daghmouri MA, Ouesleti M, Touati MA, Faten O, et al.
International journal of surgery case reports · 2020 · Case Reports
Daghmouri MA, Ben Ismail I, Ouesleti M, Tarhouni MA, et al.
Lupus · 2008 · Clinical Trial
F L, Y T, X P, L W, et al.
Surgical neurology international · 2025 · Journal Article
Kalai F, Faten O, Ben Brahem S, Ardhaoui I, et al.
Infectious agents and cancer · 2012 · Journal Article
Faten N, Agnès GD, Nadia BF, Nabil AB, et al.
BMJ case reports · 2026 · Journal Article
F A, George OK, Alex AG, Sahitya MS
International journal of surgery case reports · 2017 · Journal Article
Rateb K, Hassen BG, Leila A, Faten F, et al.
✨ Profil synthétique
IA · 29/04/2026Le Docteur Faten Kraoua-Landolsi est un rhumatologue hospitalier à Troyes. Ses publications sur PubMed couvrent divers sujets, notamment des cas cliniques, la pédiatrie, la corticothérapie et l'épidémiologie. Ses travaux suggèrent une implication dans la recherche et la prise en charge de pathologies rhumatismales chez différents patients, y compris les enfants.
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.